Skip to main content
. 2013 Aug 29;15(4):PCC.13m01520. doi: 10.4088/PCC.13m01520

Table 2.

Treatment Response and Remission Rates by Patient Subgroup

Patient Subgroup Patients, n Change in PHQ-9 Score, mean (SD) Responded to Treatment, n
(treatment response rate, %)
Achieved Remission, n (remission rate, %)
Overall 554 −8.5 (6.3) 376 (67.9) 253 (45.7)
Gender
 Female 424 −8.7 (6.4) 287 (67.7) 189 (44.6)
 Male 114 −8.0 (5.8) 79 (69.3) 59 (51.8)
Age group, y
 18–34 79 −8.6 (5.6) 50 (63.3) 39 (49.4)
 35–44 110 −8.9 (6.6) 80 (72.7) 56 (50.9)
 45–54 140 −8.6 (6.2) 89 (63.6) 60 (42.9)
 55–64 141 −8.4 (6.7) 100 (70.9) 60 (42.6)
 ≥ 65 84 −7.7 (6.1) 57 (67.9) 38 (45.2)
Monotherapy vs adjuvant therapy
 Monotherapy 52 −7.7 (5.7) 34 (65.4) 27 (51.9)
 Augmentation 502 −8.6 (6.3) 342 (68.1) 226 (45.0)
Duration of depression symptoms
 ≤ 2 y 110 −8.7 (6.4) 82 (74.5) 64 (58.2)
 > 2 y 427 −8.7 (6.4) 282 (66.0) 179 (41.9)
Not sure 17 −8.7 (6.4) 12 (70.6) 10 (58.8)

Abbreviation: PHQ-9 = 9-item Patient Health Questionnaire.